Lam Research [LRCX] Downgraded to Hold at Needham
Needham took its Lam Research [LRCX] rating to the equivalent of Hold from Buy, in a research note dated 2021-01-08. Other analysts also revised their coverage, with UBS’s analysts reiterating the shares to “a Buy” rating in a research note to investors issued in late October. Meanwhile, Stifel had maintained its rating on LRCX to […]
Lam Research [LRCX] Unchanged to Overweight at KeyBanc
KeyBanc maintained its Lam Research [LRCX] rating to the equivalent of Overweight but changed the price target to $519 from $472, in a research note dated 2021-01-06. That figure represents around a 4.94% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with UBS’s analysts reiterating the shares to […]
